Head-to-head · WeighScore
Omzo vs Wisp
The verdict
Wisp takes it — 75/100 to 54.2/100.
Wisp grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Wisp (hellowisp.com) is a US telehealth provider whose weight care vertical offers brand-name Wegovy, Zepbound, and Saxenda alongside a compounded sublingual semaglutide drops formulation at $225/month.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Omzo | Wisp |
|---|---|---|
| WeighScore | 54.2/100 | 75/100 |
| Grade | C | C |
| Scorecard rank | #459 | #59 |
| Semaglutide | Not disclosed | $225/mo (compounded oral) |
| Tirzepatide | Not disclosed | $99/mo (starting dose, brand-name) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Yes |
Graded #459 · C
Strengths
- Compounded GLP-1 (semaglutide and tirzepatide) with clinician guidance
- Free, discreet delivery on all treatments
- FSA/HSA eligible
- Multi-pillar: also women's hormone, sexual health, hair, skin, and daily health
Where it loses points
- Pricing not published on the site — shown only after the intake quiz
- Compounding pharmacy partner not named (states only 'independent state-licensed')
- States of operation not published
- Not LegitScript-certified (no certification displayed)
- Legal entity not named; governing law given only as 'the state in which Omzo operates'
Graded #59 · C
Strengths
- Broad GLP-1 menu — branded injectables (Wegovy, Zepbound, Saxenda) plus a compounded sublingual option
- LegitScript certified with named board-certified providers (Dr. Shannon Chatham DO, Andrea Sleeth WHNP-BC)
- Unusually candid about the sublingual option's limits, noting effectiveness in patients may vary
Where it loses points
- Sublingual compounded semaglutide hasn't been tested in humans, per Wisp's own page — only the injectables have FDA efficacy data
- Pharmacy partners not named
- States served not listed publicly
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.